TipRanks
Jaguar Animal Health (JAGX)
NASDAQ:JAGX
US Market
JAGX
Jaguar Animal Health
RESEARCH TOOLSreports
Want to see JAGX full AI Analyst Report?

Jaguar Animal Health (JAGX) Ratios

2,366 Followers

Jaguar Animal Health Ratios

JAGX's free cash flow for Q2 2026 was $0.16. For the 2026 fiscal year, JAGX's free cash flow was decreased by $ and operating cash flow was $-10.32. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Dec 22
Liquidity Ratios
Current Ratio
 0.69 0.50 1.63 2.00 0.74
Quick Ratio
 0.40 0.29 1.11 1.34 0.50
Cash Ratio
 0.26 0.02 0.41 0.46 0.18
Solvency Ratio
 -1.18 -0.90 -0.77 -0.88 -0.93
Operating Cash Flow Ratio
 -0.27 0.14 -1.49 -2.38 -1.09
Short-Term Operating Cash Flow Coverage
 -0.49 0.21 -2.44 -6.83 -2.08
Net Current Asset Value
$ -11.74M$ -36.67M$ -14.73M$ -17.90M$ -26.49M
Leverage Ratios
Debt-to-Assets Ratio
 0.49 1.14 0.68 0.73 0.73
Debt-to-Equity Ratio
 2.52 -2.52 5.01 7.48 -53.02
Debt-to-Capital Ratio
 0.72 1.66 0.83 0.88 1.02
Long-Term Debt-to-Capital Ratio
 0.21 -6.84 0.76 0.86 1.04
Financial Leverage Ratio
 5.17 -2.22 7.33 10.23 -72.23
Debt Service Coverage Ratio
 -2.73 -1.89 -2.99 -2.91 -1.17
Interest Coverage Ratio
 -28.98 673.25 -133.47 -5.37 -2.70
Debt to Market Cap
 13.03 19.58 4.78 30.70 882.47
Interest Debt Per Share
 324.74 9.80K 4.37K 2.82K 4.07M
Net Debt to EBITDA
 -0.25 -0.82 -0.78 -0.93 -0.88
Profitability Margins
Gross Profit Margin
82.31%67.21%83.27%79.13%83.11%
EBIT Margin
-151.47%-468.51%-333.82%-347.51%-298.36%
EBITDA Margin
-144.11%-449.38%-313.65%-335.62%-279.19%
Operating Profit Margin
-90.22%-391.87%-263.76%-351.31%-287.85%
Pretax Profit Margin
-132.73%-469.09%-335.79%-429.27%-404.78%
Net Profit Margin
-131.76%-464.20%-329.30%-423.11%-396.91%
Continuous Operations Profit Margin
-132.73%-469.09%-335.79%-429.27%-404.78%
Net Income Per EBT
99.26%98.96%98.07%98.57%98.06%
EBT Per EBIT
147.12%119.71%127.31%122.19%140.62%
Return on Assets (ROA)
-107.18%-139.43%-72.05%-81.36%-100.00%
Return on Equity (ROE)
762.51%309.06%-528.37%-832.49%7222.83%
Return on Capital Employed (ROCE)
-284.72%1935.14%-91.43%-93.24%-201.10%
Return on Invested Capital (ROIC)
-109.75%-178.29%-66.94%-81.66%-102.80%
Return on Tangible Assets
-191.79%-239.59%-110.15%-134.76%-189.72%
Earnings Yield
-24705.78%-2460.36%-517.59%-3535.53%-124532.71%
Efficiency Ratios
Receivables Turnover
 140.48 6.78 7.10 4.47 4.85
Payables Turnover
 1.03 0.43 0.37 0.41 0.35
Inventory Turnover
 0.67 0.44 0.19 0.22 0.29
Fixed Asset Turnover
 19.48 7.87 8.35 5.84 7.05
Asset Turnover
 0.81 0.30 0.22 0.19 0.25
Working Capital Turnover Ratio
 -1.96 -2.95 0.88 3.28 4.84
Cash Conversion Cycle
 189.73 45.43 995.95 836.93 295.15
Days of Sales Outstanding
 2.60 53.84 51.43 81.67 75.31
Days of Inventory Outstanding
 542.64 831.65 1.93K 1.65K 1.27K
Days of Payables Outstanding
 355.51 840.06 986.90 891.27 1.05K
Operating Cycle
 545.24 885.49 1.98K 1.73K 1.35K
Cash Flow Ratios
Operating Cash Flow Per Share
 -124.93 1.31K -3.49K -2.16K -2.83M
Free Cash Flow Per Share
 -125.40 1.30K -3.52K -2.16K -2.97M
CapEx Per Share
 0.46 5.63 27.45 0.00 143.24K
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.01 1.00 1.05
Dividend Paid and CapEx Coverage Ratio
 -269.56 231.92 -127.20 0.00 -19.76
Capital Expenditure Coverage Ratio
 -269.56 231.92 -127.20 0.00 -19.76
Operating Cash Flow Coverage Ratio
 -0.40 0.13 -0.80 -0.90 -0.95
Operating Cash Flow to Sales Ratio
 -0.24 0.50 -2.51 -3.41 -2.77
Free Cash Flow Yield
-566.57%265.82%-398.22%-2845.72%-91269.93%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 >-0.01 -0.04 -0.19 -0.03 >-0.01
Price-to-Sales (P/S) Ratio
 0.04 0.19 0.64 0.12 <0.01
Price-to-Book (P/B) Ratio
 0.02 -0.13 1.02 0.24 -0.06
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.18 0.38 -0.25 -0.04 >-0.01
Price-to-Operating Cash Flow Ratio
 -0.02 0.37 -0.25 -0.04 >-0.01
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 <0.01 <0.01 <0.01 <0.01
Price-to-Fair Value
 0.02 -0.13 1.02 0.24 -0.06
Enterprise Value Multiple
 -0.28 -0.87 -0.98 -0.97 -0.88
Enterprise Value
 11.25M 44.81M 35.96M 31.79M 29.40M
EV to EBITDA
 -0.28 -0.87 -0.98 -0.97 -0.88
EV to Sales
 0.40 3.89 3.08 3.26 2.46
EV to Free Cash Flow
 -1.66 7.76 -1.21 -0.96 -0.85
EV to Operating Cash Flow
 -1.67 7.73 -1.22 -0.96 -0.89
Tangible Book Value Per Share
 -188.45 -7.81K -1.42K -986.90 -2.03M
Shareholders’ Equity Per Share
 122.63 -3.89K 865.72 321.70 -56.19K
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 515.66 2.59K 1.39K 632.97 1.02M
Net Income Per Share
 -679.41 -12.03K -4.57K -2.68K -4.06M
Tax Burden
 0.99 0.99 0.98 0.99 0.98
Interest Burden
 0.88 1.00 1.01 1.24 1.36
Research & Development to Revenue
 0.91 2.17 1.42 1.91 1.48
SG&A to Revenue
 0.75 2.26 2.06 1.70 1.49
Stock-Based Compensation to Revenue
 -0.04 -0.07 0.14 0.22 0.28
Income Quality
 -5.93 -0.38 0.75 0.79 0.67
Currency in USD